Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005926 |
---|---|
Receipt number | R000007000 |
Scientific Title | Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for taxane/platinum resistant ovarian, fallopian tube or primary peritoneal cancer |
Date of disclosure of the study information | 2011/07/05 |
Last modified on | 2018/02/06 17:26:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/07/05 18:19:46 | ||
2 | Update | 2011/07/05 21:17:22 | Date of disclosure of the study information |
|
3 | Update | 2011/07/05 21:22:12 | Public title |
|
4 | Update | 2011/07/08 19:44:07 | Interventions/Control_1 Interventions/Control_1 |
|
5 | Update | 2014/07/07 14:48:54 | Email |
|
6 | Update | 2017/07/09 09:07:29 | Name of primary person or sponsor Institute Organization Organization |
|
7 | Update | 2017/07/09 09:11:09 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
|
8 | Update | 2017/07/09 09:12:37 | Recruitment status |
|
9 | Update | 2018/02/06 17:26:24 | Publication of results URL related to results and publications Results |